Find your path to Patrick
48 people in our graph share verified history with Patrick β schools, employers, funds. One of them is your warm intro.
About
Patrick Lucy is Chief Executive Officer of Wheeler Bio, Inc., with approximately 35 years of experience in the biotechnology industry. He is a founder of Pfenex Inc. (NYSE: PFNX), where he was part of the leadership team that completed the company's spin-out from The Dow Chemical Company and its NYSE initial public offering, and has served as CEO of three companies. His background includes business development transactions totaling over $1.5 billion, non-dilutive government funding through agencies such as BARDA, NIAID/DMID, DoD, DTRA, and DARPA, and areas including licensing, alliance management, and biopharmaceutical processing and facility design.
Chief Executive Officer at Wheeler Bio
Intro paths
In turn, Patrick can intro founders to Wheeler Bio's investors below.
Wheeler Bio's investors Β· 4
Co-founders at Wheeler Bio

Experience
- Wheeler Bio, Inc.Chief Executive Officercurrent2024 β presentBoston and Oklahoma City
- Dyadic International, Inc.Chairman of the Boardcurrent2024 β present
- Dyadic International, Inc.Board Member2021 β 2024
- RoslinCT (Former Lykan Bioscience)President and Chief Executive Officer2023 β 2024United States and UK
- RoslinCT (Former Lykan Bioscience)Board Member2021 β 2024
- RoslinCT (Former Lykan Bioscience)President and Chief Executive Officer2021 β 2023United States
- RoslinCT (Former Lykan Bioscience)President and Chief Operating Officer2021
- Leidos - Explorations in Global Health (ExGloH) - MicroTide, Inc.Scientific Advisory Board Member2020 β 2021
- Pfenex IncSenior Vice President & Chief Business Officer2014 β 2020San Diego, California
- Pfenex IncInterim Chief Executive Officer, President and Secretary & Chief Business Officer2017Greater San Diego Area
- Pfenex IncVice President of Business Development & Marketing2009 β 2014
- Alliance for BiosecurityBoard Member2017 β 2018Washington D.C. Metro Area
- Association for Accessible MedicinesBoard Member2017 β 2018Washington D.C. Metro Area
- The Biosimilars CouncilBoard Member (Vice Chair)2017 β 2018Washington D.C. Metro Area
- The Dow Chemical Company (Dowpharma)Global Business Development Leader/Business Builder2004 β 2009
- The Dow Chemical Company (Dowpharma)Director of Business Development2002 β 2004
- Collaborative BioAlliance (acquired by The Dow Chemical Company in 2000)Director of Business Development - Eastern U.S.1999 β 2002
- LonzaValidation Manager1998 β 1999
- LonzaCapital Project Manager1998 β 1999
- LonzaQC Biochemistry Supervisor1996 β 1998
- Repligen CorporationQC Biochemistry1991 β 1996
Skills & more
+10 more
BiotechnologyDrug DevelopmentPharmaceutical IndustryLicensingBusiness DevelopmentProtein ChemistryCommercializationAntibodiesINDBuilding DesignFrom Patrick's professional profile.
Frequently asked questions
- Who is Patrick Lucy?
- Patrick Lucy is Chief Executive Officer of Wheeler Bio, Inc., with approximately 35 years of experience in the biotechnology industry. He is a founder of Pfenex Inc. (NYSE: PFNX), where he was part of the leadership team that completed the company's spin-out from The Dow Chemical Company and its NYSE initial public offering, and has served as CEO of three companies. His background includes business development transactions totaling over $1.5 billion, non-dilutive government funding through agencies such as BARDA, NIAID/DMID, DoD, DTRA, and DARPA, and areas including licensing, alliance management, and biopharmaceutical processing and facility design.
- Where does Patrick Lucy work?
- Patrick Lucy is Chief Executive Officer at Wheeler Bio.
- Where did Patrick Lucy go to school?
- Patrick Lucy studied at Villanova University (BS, Biology).
Same school
Also attended Villanova University218
+ 212 more
Shared employers
Also worked at Pfenex Inc2
Also worked at Association for Accessible Medicines1
Also worked at The Dow Chemical Company (Dowpharma)67
+ 61 more
























